The Delaware Board of Nursing Rules and Regulations requires Registered and Licensed Practical Nurses to complete continuing education (CE) on substance abuse. Starting with your next renewal, at least three of your required contact hours must be in the area of substance abuse. (Section 188.8.131.52.1).
This course fulfills the Delaware Board of Nursing's requirement for 3 units of coursework on substance abuse.
- Contact hours:
- Pharmacotherapy hours: 3
- Expiration date: October 1, 2019
- Course price: $29
Evidence-based information about the problem of chemical dependency in the workplace, warning signs of substance use disorder, drug diversion and controlled substances, including safeguards to prevent diversion, misuse, abuse, addiction, and overdose deaths.
ATrain Education, Inc. is an approved provider by the American Occupational Therapy Association. The following course information applies to occupational therapy professionals:
- Target Audience: Occupational Therapists, OTAs
Criteria for Successful Completion
80% or higher on the post test, a completed evaluation form, and payment where required. No partial credit will be awarded.
Conflict of Interest/Commercial Support
Objectives: When you finish this course you will be able to:
- Describe the 5 Schedules of medications under the Controlled Substances Act and give examples of each.
- Compare and contrast acute and chronic pain and discuss the trends in treatment of chronic pain.
- Identify the demographic of drug abusers in U.S. society and cite five groups from whom they may get drugs.
- State 7 symptoms of drug withdrawal from opioids at and least 4 best practice recommendations by the Medical Society of Delaware.
- Name 3 categories of risk factors for opioid abuse and addiction and demonstrate ability to create a treatment plan for an abuser.
- Explain informed consent and name 5 elements set forth by the Federation of Medical Boards.
- List the 7 assessment tools for monitoring ongoing opioid therapy.
- State at least 5 precautions to follow when tapering the patient off of opioids.
- Describe Delaware’s Prescription Drug Monitoring Programs (PDMPs) and explain drug take-back programs.